Dr. Christopher L Pecsok, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4158 Crossgate Ln, Blue Ash, OH 45236 Phone: 513-236-9017 |
Dr. David M Boynton, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 9500 Kenwood Rd, Blue Ash, OH 45242 Phone: 513-773-1214 Fax: 513-745-9247 |
Arc Physical Medicine & Rehabilitation Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4610 Carlynn Dr, Blue Ash, OH 45241 Phone: 574-361-8519 |
Dr. Michael Wayne Rengert, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4434 Carver Woods Dr, Blue Ash, OH 45242 Phone: 513-489-9515 Fax: 513-489-8350 |
Sycamore Chiropractic And Nutrition Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 9500 Kenwood Rd, Blue Ash, OH 45242 Phone: 513-773-1214 |
Dr. Joyce Bonnie Mcdowell, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 10428 Kenwood Rd, Blue Ash, OH 45242 Phone: 513-791-6766 Fax: 513-791-0340 |
Dr. Joseph W Piwoszkin, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4610 Carlynn Dr, Blue Ash, OH 45241 Phone: 574-361-8519 |
News Archive
Today the Proceedings of the National Academy of Sciences publishes a paper by Temple University researchers that details one of the functions of the c-myb gene (which leukemia cells depend on for proliferation), the formation of white blood cells.
Memory lapses and changes in mental functions occur naturally as we get older. But for many women going through menopause, these memory lapses occur more frequently.
UNICEF and the WHO "are warning of an alarming upsurge in cholera across West Africa's Sahel region, the area at the southern fringe of the Sahara Desert running from Mauritania to Chad," VOA News reports.
United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.
There are important, long-term gains from hastening the processes around surgical interventions against epilepsy - before the disease has had too much negative impact on brain functions and patients' lives.
› Verified 2 days ago